We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Mylan Sues FDA, Says it Fumbled First-Filer Move on Provigil
Mylan Sues FDA, Says it Fumbled First-Filer Move on Provigil
April 13, 2012
In the latest patent commotion over Provigil, Mylan Pharmaceuticals is suing the FDA over its recent decision to grant Teva sole first-filer status for a generic of the sleep disorder drug, saying the FDA overlooked an anti-competitive legal loophole.